doi: 10.3390/curroncol13050019.
Receptor tyrosine kinases: role in cancer progression
Affiliations
- PMID: 22792017
- PMCID: PMC3394603
- DOI: 10.3390/curroncol13050019
Item in Clipboard
Receptor tyrosine kinases: role in cancer progression
Curr Oncol.
2006 Oct.
No abstract available
Keywords: Receptor tyrosine kinase; cancer.
Similar articles
-
Receptor tyrosine kinases in Drosophila development.Cold Spring Harb Perspect Biol. 2013 Jun 1;5(6):a009050. doi: 10.1101/cshperspect.a009050. Cold Spring Harb Perspect Biol. 2013. PMID: 23732470 Free PMC article. Review.
-
Tobacco Smoke Condensate Induces Morphologic Changes in Human Papillomavirus-Positive Cervical Epithelial Cells Consistent with Epithelial to Mesenchymal Transition (EMT) with Activation of Receptor Tyrosine Kinases and Regulation of TGFB.Int J Mol Sci. 2024 Apr 30;25(9):4902. doi: 10.3390/ijms25094902. Int J Mol Sci. 2024. PMID: 38732119 Free PMC article.
-
Zap-70-independent Ca(2+) mobilization and Erk activation in Jurkat T cells in response to T-cell antigen receptor ligation.Mol Cell Biol. 2001 Nov;21(21):7137-49. doi: 10.1128/MCB.21.21.7137-7149.2001. Mol Cell Biol. 2001. PMID: 11585897 Free PMC article.
-
Modulation of tyrosine receptor imposed by estrogen in memory and cognition in female rats.Behav Brain Res. 2025 Feb 28;479:115340. doi: 10.1016/j.bbr.2024.115340. Epub 2024 Nov 14. Behav Brain Res. 2025. PMID: 39549875
-
Exploration of structural requirements for the inhibition of VEGFR-2 tyrosine kinase: Binding site analysis of type II, 'DFG-out' inhibitors.J Biomol Struct Dyn. 2022 Aug;40(12):5712-5727. doi: 10.1080/07391102.2021.1872417. Epub 2021 Jan 18. J Biomol Struct Dyn. 2022. PMID: 33459187 Review.
Cited by
-
ImmunoPET Imaging of Insulin-Like Growth Factor 1 Receptor in a Subcutaneous Mouse Model of Pancreatic Cancer.Mol Pharm. 2016 Jun 6;13(6):1958-66. doi: 10.1021/acs.molpharmaceut.6b00132. Epub 2016 Apr 26. Mol Pharm. 2016. PMID: 27054683 Free PMC article.
-
Helping the Released Guardian: Drug Combinations for Supporting the Anticancer Activity of HDM2 (MDM2) Antagonists.Cancers (Basel). 2019 Jul 19;11(7):1014. doi: 10.3390/cancers11071014. Cancers (Basel). 2019. PMID: 31331108 Free PMC article. Review.
-
Targeting PI3K/Akt signal transduction for cancer therapy.Signal Transduct Target Ther. 2021 Dec 16;6(1):425. doi: 10.1038/s41392-021-00828-5. Signal Transduct Target Ther. 2021. PMID: 34916492 Free PMC article. Review.
-
Roles of EphA2 Receptor in Angiogenesis Signaling Pathway of Glioblastoma Multiforme.Malays J Med Sci. 2018 Nov;25(6):22-27. doi: 10.21315/mjms2018.25.6.3. Epub 2018 Dec 28. Malays J Med Sci. 2018. PMID: 30914876 Free PMC article. Review.
-
Biologics, Immunotherapies, and Cytotoxic Chemotherapy for Hepatocellular Carcinoma following Current Recommendations by the BCLC: A Review of Agents.Semin Intervent Radiol. 2024 Mar 14;41(1):84-91. doi: 10.1055/s-0043-1778660. eCollection 2024 Feb. Semin Intervent Radiol. 2024. PMID: 38495256 Review. No abstract available.
References
-
- Pawson T, Scott JD. Protein phosphorylation in signalling— 50 years and counting. Trends Biochem Sci. 2005;30:286–90. - PubMed
-
- Wiley HS, Burke PM. Regulation of receptor tyrosine kinase signaling by endocytic trafficking. Traffic. 2001;2:12–18. - PubMed
-
- Peschard P, Park M. Escape from cbl-mediated downregulation: a recurrent theme for oncogenic deregulation of receptor tyrosine kinases. Cancer Cell. 2003;3:519–23. - PubMed
-
- Blume–Jensen P, Hunter T. Oncogenic kinase signalling. Nature. 2001;411:355–65. - PubMed
LinkOut - more resources
Full Text Sources